Association of
International
Pharmaceutical
Manufacturers
Ассоциация
международных
фармацевтических
производителей
+7 (495) 933-7040
SECRETARIAT@AIPM.ORG
RU EN

News

To Mark Its 25th Anniversary AIPM launches the "On the Way to 80+" Communication Campaign. 23.09.2019

Representatives of the Association of International Pharmaceutical Manufacturers talk about their contribution to achieving key national health indicators: #aipm25to80, #pharma_onthewayto80, #вместеради80плюс, #aipm25

On the Way from 25 to 80+: Impact of Pharmaceutical Industry in Achieving National Healthcare Goals 17.05.2019 Representatives of the international pharmaceutical industry confirmed their commitment to contribute to the implementation the targets set by the government
25th Russian Pharmaceutical Forum will be taking place in St.Petersburg on 14 – 15 May, 2019. AIPM and Russian Pharmaceutical Forum celebrates 25th Anniversaries. 02.04.2019 25th Russian Pharmaceutical Forum will take place in St.Petersburg on 14th – 15th May, 2019.  Don’t miss this unique opportunity to meet with all international and local pharmaceutical market players in Russia to discuss sector challenges and exchange the latest news!
Leading associations of the pharmaceutical industry identified risks to drug provision due to a radical change in T&T concept 18.12.2018 December 18, 2018, Moscow – The pharmaceutical industry professional associations called for maintaining the technical conditions for implementing the project for monitoring the movement of medicines within the framework of the requirements developed earlier in the pilot project. At the same time, the Association of Russian Pharmaceutical Manufacturers, the Association of International Pharmaceutical Manufacturers, the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union, the APF National Association of Pharmaceutical and Medical Products Manufacturers, the Soyuzpharma Association of Pharmaceutical Institutions reaffirmed the principled commitment of their associations to the implementation of a system of labeling and traceability of medicines.
AIPM welcomes new members: Krewel Meuselbach GmbH and Veolia Water Technologies became members of the Association 11.12.2018 December 11, 2018, Moscow – The Association of International Pharmaceutical Manufacturers (AIPM) announces the expansion of its membership. Following the results of the AIPM General Meeting, the German pharmaceutical company Krewel Meuselbach GmbH and French company Veolia Water Technologies were elected as new members of the association. 
Developing Cross-Industry Responsible Self-Regulation: The Federal Antimonopoly Service of the Russian Federation and Professional Associations Have Agreed to Common Approaches to Advertising Legislative Compliance 13.11.2018 On November 7, 2018, the leading professional associations in the pharmaceutical industry and communication services market, in the presence of FAS Russia, signed the “Recommendations on compliance with legislation on advertising of non-prescription medicines” in Moscow. It was developed in close cooperation with FAS Russia.  
Effective Pharmacovigilance system is the Basis of Safety and Wellbeing of Patients 17.10.2018 The first International Conference “PHARMACOVIGILANCE. Challenges and opportunities”, unprecedented in its speakers and content, took place on October 10, 2018 in Moscow. More than 600 experts in the field of drug safety monitoring took part in the Conference. The event was organised by the Federal Service for Surveillance in Healthcare (Roszdravnadzor) and the Association of International Pharmaceutical Manufacturers (AIPM).
Electronic submissions in EAEU & ICH region - current practice & future developments for pharma regulation 19.06.2018

On June 18, 2018 in Moscow the Regulatory Workshop was organized by Eurasian Economic Commission and AIPM & EFPIA with participation (F2F & VC format) of regulatory authorities of EAEU member-states, EU regulators, IT specialists and industry to discuss regulatory aspects, practical implementation issues and road map of eCTD implementation in ICH region & electronic submissions in EAEU region.

International pharmaceutical industry offers a new level of professional dialogue and partnership 23.05.2018

On May 15, 2018 in the frame of Russian Pharmaceutical Forum in St. Petersburg, a press briefing of the Association of International Pharmaceutical Manufacturers (AIPM) was held, entitled “PHARMA 2030: what is needed to develop innovation and attract investment in the pharmaceutical industry in Russia?”.

THE COMMON MARKET OF MEDICINES WITHIN THE EURASIAN ECONOMIC UNION WAS PRESENTED IN THE EUROPEAN UNION 04.05.2018

At the end of April, 2018 the EAEU common market, regulating the circulation of medicines in the Union, was officially presented in Brussels within the framework of the international conference “Regional pharmaceutical markets of the European Union and the Eurasian Economic Union – trends, challenges and best regulatory practices”.

Vasily Ignatiev, CEO, R-Pharm, became Vice Chairman of the AIPM Board of Directors 21.02.2018

February 21, 2018, Moscow – The Association of International Pharmaceutical Manufactures (AIPM) announces that according to the Statutes and by the decision of the AIPM Board of Director, Vasily Ignatiev, CEO, R-Pharm, has been elected Vice Chairman of the AIPM Board of Directors.

AIPM welcomes the new member: the international pharmaceutical company CSL Behring has become a member of the Association 07.04.2017

On April 7, 2017 – Association of international pharmaceutical manufacturers (AIPM) announces the expansion of its membership. AIPM General Assembly held on April 6, 2017 unanimously decided to include the international pharmaceutical company CSL Behring in the AIPM.

The Industry Discloses Information 04.07.2016 By July 1, 2016, in accordance with the requirements of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Code of Practice of the Association of International Pharmaceutical Manufacturers (AIPM), which is a member of EFPIA, international pharmaceutical companies had published data on transfers of value to healthcare professionals and organizations in 2015.
Best International Practices — the Foundation for the Common Market of Medicines within the Eurasian Economic Union (EAEU) 28.09.2015

Prior to the launch of the common market of medicines on the territory of the EAEU member states, a unique round table for the regulators and the pharmaceutical industry, the “International experience of the creation of a regional market of medicines” (experience and example of the European Union & Eurasian Economic Union), was held in Moscow. The Eurasian Economic Commission (EEC), the Association of International Pharmaceutical Manufacturers (AIPM), and the European Federation of Pharmaceutical Industries and Associations (EFPIA) were co-organizers of the event.

AIPM took part in a press conference on the opening of joint production of IPSEN and "Raduga Production" (ROSTA) 23.07.2015

The opening ceremony was held with participation of Olga Kazanskaya, Vice-Governor of Saint Petersburg, Marc de Garidel, Chairman of Board and Chief Executive Officer of IPSEN, David Panikashvili, President of Pharmaceutical Group ROSTA, Marina Veldanova, Head of representative office of IPSEN in Russia, Vladimir Shipkov, Executive Manager of Association of International Pharmaceutical Manufacturers (AIPM), Jean-Maurice Ripert, Ambassador of France in Russia and recognized experts of pharmaceutical sector.

Innovative Development — a Choice to the Benefit of Patients 20.05.2015

International pharmaceutical industry considers it necessary to maintain long-term strategic priorities of the state during implementation of the anti-crisis plan

International pharmaceutical companies – Angelini and Glenmark – become members of AIPM 14.04.2015

April 14, 2015 – Association of international pharmaceutical manufacturers (AIPM) announces extension to its member list. The decision to include two new companies – Angelini and Glenmark, was made during AIPM General Managers Meeting.
 

AIPM and AESGP: New Prospects for Partnership for Improving the Quality of Life of Russian People 16.02.2015

The Associations discussed the specifics of the distribution of non-prescription drugs, as well as the implementation of the concept of responsible self-medication in Russia February 16, 2015 - The Board of Directors of the Association of the European Self-Medication Industry (AESGP) and AESGP Working Group on the Development of OTC-Market in Russia meetings were held in Moscow for the first time.

Book presentation: Great Medicines In The Fight For Life 12.02.2015

The first book written for public at large about medicines has been presented in Moscow. The authors, brought together by Vladislav Dorofeev, a well-known journalist and writer, collected facts and wrote their stories of the inventions and discoveries of ether and aspirin, haloperidol and smallpox vaccine, penicillin and Prozac, Viagra and Herceptin, hydrocortisone and cocaine, Losec and vitamins, insulin and lidocaine, and many others. By telling all these stories in an entertaining way, and invariably keeping true to the facts, the authors were not only able to take readers on a fascinating journey into the history and the present day of the drugs in our medicine box, but also provided an insight into pharmacy.

Development of Pharmaceutical Market in Russia: Yesterday, Today, and Tomorrow. 20 years for better health and life in Russia. 17.06.2014

Representatives of international pharmaceutical industry shared their vision towards the solutions of key problems of the Russian pharmaceutical market and discussed the most important priorities for its further development.

June 17, 2014, St. Petersburg — As part of the 20th Russian Pharmaceutical Forum, the Association of International Pharmaceutical Manufacturers (AIPM), which is also celebrating its 20th anniversary this year, has initiated a discussion of the most pressing issues for today's pharmaceutical market, including the prospects for development of healthcarein the Russian Federation, increasing the innovative potential of local pharmaceutical industry, improving the regulatory system, building a modern drug provision system, etc.

Up